Tourettes Syndrome Drugs Market by Product, Distribution Channel and Geography - Forecast and Analysis 2023-2027

Published: Jun 2023 Pages: 149 SKU: IRTNTR75738

Tourettes Syndrome Drugs Market Analysis Report 2023-2027:

The global Tourettes syndrome drugs market size is estimated to grow by USD 598.85 million at a CAGR of 6.69% between 2022 and 2027. 

  • Rising awareness about Tourette syndrome in individuals is done by many government and non-government organizations.
  • The Centers for Disease Control and Prevention (CDC) and the Tourette Association of America are working in partnership to provide awareness and education on Tourette to various audiences such as families, individuals, and the public.
  • The program, named "Tourette Health and Education Program" (THEP), is working for the information and education on Tourette syndrome to be shared.
  • Tourettes Action organizations are taking support from social media to raise awareness about Tourettes syndrome. Especially on Tourettes Awareness Day, the organization asks people to change their profile pictures with a Tourettes action twibbon.
  • The organization is also making TSelfie with one eye blinking on social media because this is an incredible communication tool.
  • Hence, rising awareness about Tourette syndrome will drive the growth of the global Tourette's syndrome drugs market during the forecast period.

Technavio has segmented the market into product, distribution channel, and geography.

  • The product segment is classified into antipsychotics and non-antipsychotics
  • The distribution channel segment is classified into offline and online
  • The geography segment is classified into key regions such as North America, Europe, Asia, and the Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. 

What will be the size of the Tourettes Syndrome Drugs Market During the Forecast Period?

To learn more about this report, Request Free Sample

The market share growth by the antipsychotic segment will be significant during the forecast period. Antipsychotic drugs held the largest share in the global Tourette's syndrome drugs market due to the ability of antipsychotic drugs to treat tics compared to non-antipsychotic drugs. These drugs are developed for treating schizophrenia and are hence they are known as antipsychotic drugs. Antipsychotic drugs mainly work by blocking dopamine in the brain, majorly in the D2 receptor.

Get a glance at the market contribution of various segments View a PDF Sample

The antipsychotic segment was valued at USD 695.33 million in 2017. Because some drugs are the most useful medications for minimizing tics dopamine is strongly connected with Tourette syndrome. Drugs such as Fluphenazine, Haloperidol (Haldol), pimozide (Orap), and risperidone (Risperdal) are the most used antipsychotic drugs for the treatment of Tourette syndrome.  However, due to the growing reliability of end-users such as hospitals, healthcare providers, and clinics on antipsychotic drugs for the treatment of Tourette's syndrome, the antipsychotic segment of the global Tourette's syndrome drugs market is expected to rise during the forecast period.

Tourettes Syndrome Drugs Market Segmentation by Distribution Channel

Offline segment

The offline segment includes retail pharmacies and hospitals. Due to the increasing awareness and prevalence of the condition and breakthroughs in novel treatment options, the global Tourette's syndrome drugs market is predicted to grow significantly during the forecast period. Retail pharmacies are the most accessible and convenient source of medication because they provide a wide variety of drugs. The increasing prevalence of Tourette syndrome has raised the demand for medicines and other treatments. Hence, the offline segment is expected to drive the growth of the global

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America held the largest share of the global Tourette's syndrome drugs market owing to the factors such as the high incidences of Tourette syndrome, a highly aware population, favorable government initiatives such as reimbursements, and advanced healthcare infrastructure. Healthcare facilities in the US are having a positive impact on the growth of the market. Doe to the implementation of the Affordable Care Act in March 2010 has rapidly changed the business environment of the pharmaceutical industry in the US. This compels vendors and healthcare facilities to provide technologies and medical services at an affordable cost without compromising the clinical efficacy of drugs and therapeutics.

Moreover, in the US, government bodies are doing awareness campaigns for effectively managing Tourettes syndrome. For instance, the CDC plays an important role in integrating mental well-being with public health. Every year the CDC uses the Behavioral Risk Factor Surveillance System using a telephone-based questionnaire to track the health and risk behavior of people in the US. Besides, the HSR and D-initiated program Collaborative Care for Depression in the Primary Care Setting. Such campaigns increase the awareness of Tourette's syndrome among people, which will drive the growth of the regional Tourette syndrome drugs market during the forecast period.

COVID Recovery Analysis

The outbreak of COVID-19 in 2020 negatively affected the growth of the regional Tourettes syndrome drugs market. However, due to the initiation of large-scale COVID-19 vaccination drives by the government across the region in the second half of 2020 resulted in the resumption of operations in various facilities, including therapy centers. In addition, the adoption of online channels to procure medications for Tourette's syndrome, along with the resumption of activities in therapy centers and other related services, are contributing to the growth of the Tourettes syndrome drugs market in North America during the forecast period.

Buy Now Full Report and Discover More

Key Tourettes Syndrome Drugs Market Players 

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

Eli Lilly and Co.: The company offers Tourette syndrome drugs which are used to treat symptoms of attention deficit hyperactivity disorder in children of ages six to twelve along with adults.

  • Asarina Pharma AB
  • AstraZeneca
  • Bausch Health Co. Inc.
  • Catalyst Pharmaceuticals Inc.
  • Emalex Biosciences Inc.
  • H Lundbeck AS
  • Johnson and Johnson Services Inc.
  • Medtronic Plc
  • Otsuka Holdings Co. Ltd.
  • Paragon Biosciences LLC
  • Questex LLC
  • Reviva Pharmaceuticals Holdings Inc
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Tourettes Syndrome Drugs Market: Key Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Significant Tourettes Syndrome Drugs Market Trends

Increasing R&D investments for Tourette syndrome is the primary trend in the global Tourette's syndrome drugs market. The increase in R&D activities by pharmaceutical vendors such as AstraZeneca, Eli Lilly and Co., Johnson and Johnson, and Otsuka Holdings Co. Ltd. to develop new drugs for the treatment of Tourettes syndrome is a key factor that is driving the growth of the global Tourette's syndrome drugs market.

Moreover, For example, In November 2022, Emalex Biosciences Inc. raised Series D funds of approximately USD 250 million led by Bain Capital Life Sciences for the progress of the development of an investigational new drug for Tourette syndrome. Thus, the Increasing R&D investments by major players will drive the growth of the global Tourette's syndrome drugs market during the forecast period.

Major Tourettes Syndrome Drugs Market Challenges

The social stigma associated with Tourette syndrome and the lack of awareness among people is the major challenge for the growth of the global Tourette's syndrome drugs market. Due to the lack of adequate knowledge about Tourette's syndrome, this is poorly understood in many parts of the world. Especially in low-income countries of Africa and South America because of the low literacy rates which can lead to ignorance about possible treatment options such as Tourette's syndrome drugs. Therefore, it is associated with stigmas, such as dejection, in most parts of the region. Most people do not know what to do about Tourettes syndrome even when they find it.

Furthermore, ignorance of Tourette syndrome results in early mature loss of self-dependence, reduced participation in social interactions, and low self-confidence. Stigmas related to Tourette syndrome not only affect the well-being of a person but also affect the volume consumption of the drugs used for the treatment. In addition, inaccurate assumptions may result in wrong interpretations about the impact of the disease. This can force caregivers to refrain from attending to their patients, which can exacerbate the condition of the patient. Hence, social stigmas associated with Tourette's syndrome patients require undergoing diagnosis, which results in reduces adoption of drugs and, Therefore, will become a challenge for the growth of the global Tourette's syndrome drugs market during the forecast period.

Buy Now Full Report and Discover More

Key Tourettes Syndrome Drugs Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Tourettes Syndrome Drugs Market Customer Landscape

Segment Overview

The Tourettes syndrome drugs market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook (USD Million, 2017 - 2027)
    • Antipsychotics
    • Non-antipsychotics
  • Distribution Channel Outlook (USD Million, 2017 - 2027)
    • Offline
    • Online
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Rest Of The World(ROW)
      • Argentina
      • Brazil
      • Australia

Tourettes Syndrome Drugs Market Scope

Report Coverage

Details

Page number

149

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.69%

Market growth 2023-2027

USD 598.85 million

Market structure

Fragmented

YoY growth 2022-2023(%)

5.53

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 43%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Asarina Pharma AB, AstraZeneca, Bausch Health Co. Inc., Catalyst Pharmaceuticals Inc., Eli Lilly and Co., Emalex Biosciences Inc., H Lundbeck AS, Johnson and Johnson Services Inc., Medtronic Plc, Otsuka Holdings Co. Ltd., Paragon Biosciences LLC, Questex LLC, Reviva Pharmaceuticals Holdings Inc, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Tourettes Syndrome Drugs Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the tourettes syndrome drugs market between 2023 and 2027
  • Precise estimation of the tourettes syndrome drugs market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Vendor landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on vendor position and Classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of tourettes syndrome drugs market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global Tourettes syndrome drugs market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global tourettes syndrome drugs market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Distribution Channel Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Antipsychotics - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Antipsychotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Antipsychotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Antipsychotics - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Antipsychotics - Year-over-year growth 2022-2027 (%)
    • 6.4 Non-antipsychotics - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Non-antipsychotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Non-antipsychotics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Non-antipsychotics - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Non-antipsychotics - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 46: Chart on Comparison by Distribution Channel
      • Exhibit 47: Data Table on Comparison by Distribution Channel
    • 7.3 Offline - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
    • 7.4 Online - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Distribution Channel
      • Exhibit 56: Market opportunity by Distribution Channel ($ million)
      • Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ million)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 Asarina Pharma AB
              • Exhibit 107: Asarina Pharma AB - Overview
              • Exhibit 108: Asarina Pharma AB - Product / Service
              • Exhibit 109: Asarina Pharma AB - Key offerings
            • 12.4 AstraZeneca
              • Exhibit 110: AstraZeneca - Overview
              • Exhibit 111: AstraZeneca - Product / Service
              • Exhibit 112: AstraZeneca - Key news
              • Exhibit 113: AstraZeneca - Key offerings
            • 12.5 Bausch Health Co. Inc.
              • Exhibit 114: Bausch Health Co. Inc. - Overview
              • Exhibit 115: Bausch Health Co. Inc. - Business segments
              • Exhibit 116: Bausch Health Co. Inc. - Key news
              • Exhibit 117: Bausch Health Co. Inc. - Key offerings
              • Exhibit 118: Bausch Health Co. Inc. - Segment focus
            • 12.6 Catalyst Pharmaceuticals Inc.
              • Exhibit 119: Catalyst Pharmaceuticals Inc. - Overview
              • Exhibit 120: Catalyst Pharmaceuticals Inc. - Product / Service
              • Exhibit 121: Catalyst Pharmaceuticals Inc. - Key offerings
            • 12.7 Eli Lilly and Co.
              • Exhibit 122: Eli Lilly and Co. - Overview
              • Exhibit 123: Eli Lilly and Co. - Product / Service
              • Exhibit 124: Eli Lilly and Co. - Key news
              • Exhibit 125: Eli Lilly and Co. - Key offerings
            • 12.8 Emalex Biosciences Inc.
              • Exhibit 126: Emalex Biosciences Inc. - Overview
              • Exhibit 127: Emalex Biosciences Inc. - Product / Service
              • Exhibit 128: Emalex Biosciences Inc. - Key offerings
            • 12.9 H Lundbeck AS
              • Exhibit 129: H Lundbeck AS - Overview
              • Exhibit 130: H Lundbeck AS - Product / Service
              • Exhibit 131: H Lundbeck AS - Key offerings
            • 12.10 Johnson and Johnson Services Inc.
              • Exhibit 132: Johnson and Johnson Services Inc. - Overview
              • Exhibit 133: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 134: Johnson and Johnson Services Inc. - Key news
              • Exhibit 135: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 136: Johnson and Johnson Services Inc. - Segment focus
            • 12.11 Medtronic Plc
              • Exhibit 137: Medtronic Plc - Overview
              • Exhibit 138: Medtronic Plc - Business segments
              • Exhibit 139: Medtronic Plc - Key news
              • Exhibit 140: Medtronic Plc - Key offerings
              • Exhibit 141: Medtronic Plc - Segment focus
            • 12.12 Otsuka Holdings Co. Ltd.
              • Exhibit 142: Otsuka Holdings Co. Ltd. - Overview
              • Exhibit 143: Otsuka Holdings Co. Ltd. - Business segments
              • Exhibit 144: Otsuka Holdings Co. Ltd. - Key offerings
              • Exhibit 145: Otsuka Holdings Co. Ltd. - Segment focus
            • 12.13 Paragon Biosciences LLC
              • Exhibit 146: Paragon Biosciences LLC - Overview
              • Exhibit 147: Paragon Biosciences LLC - Product / Service
              • Exhibit 148: Paragon Biosciences LLC - Key offerings
            • 12.14 Questex LLC
              • Exhibit 149: Questex LLC - Overview
              • Exhibit 150: Questex LLC - Product / Service
              • Exhibit 151: Questex LLC - Key offerings
            • 12.15 Reviva Pharmaceuticals Holdings Inc
              • Exhibit 152: Reviva Pharmaceuticals Holdings Inc - Overview
              • Exhibit 153: Reviva Pharmaceuticals Holdings Inc - Product / Service
              • Exhibit 154: Reviva Pharmaceuticals Holdings Inc - Key offerings
            • 12.16 Sun Pharmaceutical Industries Ltd.
              • Exhibit 155: Sun Pharmaceutical Industries Ltd. - Overview
              • Exhibit 156: Sun Pharmaceutical Industries Ltd. - Product / Service
              • Exhibit 157: Sun Pharmaceutical Industries Ltd. - Key offerings
            • 12.17 Teva Pharmaceutical Industries Ltd.
              • Exhibit 158: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 159: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 162: Teva Pharmaceutical Industries Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 163: Inclusions checklist
                • Exhibit 164: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 165: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 166: Research methodology
                • Exhibit 167: Validation techniques employed for market sizing
                • Exhibit 168: Information sources
              • 13.5 List of abbreviations
                • Exhibit 169: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              tourettes syndrome drugs market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis